Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Canadian Respiratory Journal|September 7, 2018
Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced StageMakoto Shioya, Mitsuo Otsuka, Gen Yamada, et al.
Journal of Gastroenterology|November 23, 2015
NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel diseaseAyumi Asada, Atsushi Nishida, Makoto Shioya, et al.
International Journal of Molecular Medicine|May 10, 2007
Interleukin-31 stimulates production of inflammatory mediators from human colonic subepithelial myofibroblastsYuhki Yagi, Akira Andoh, Atsushi Nishida, et al.
Clinical Journal of Gastroenterology|March 22, 2015
A case of Crohn's disease that developed anti-infliximab and anti-adalimumab antibodiesKenichiro Takahashi, Takehide Fujimoto, Makoto Shioya, et al.
Molecular Medicine Reports|November 5, 2011
Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patientsTakashi Nishimura, Rie Osaki, Makoto Shioya, et al.
Biological & Pharmaceutical Bulletin|November 3, 2015
Quantification of Sorafenib in Human Serum by Competitive Enzyme-Linked Immunosorbent AssayTetsuya Saita, Yuta Yamamoto, Satoshi Noda, et al.
Inflammatory Bowel Diseases|January 12, 2016
Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel DiseaseAtsushi Nishida, Kentaro Hidaka, Toshihiro Kanda, et al.
Digestive Diseases and Sciences|July 17, 2008
Inhibitory effects of short-chain fatty acids on matrix metalloproteinase secretion from human colonic subepithelial myofibroblastsTakato Kawamura, Akira Andoh, Atsushi Nishida, et al.
Pancreas|September 30, 2015
Eotaxin-3 (CCL26) Expression in Human Pancreatic MyofibroblastsTakehide Fujimoto, Hirotsugu Imaeda, Kenichiro Takahashi, et al.
Molecular Medicine Reports|November 5, 2011
Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infectionRie Osaki, Takashi Nishimura, Makoto Shioya, et al.
Pageof 4